Xeris Pharmaceuticals (XERS)
(Delayed Data from NSDQ)
$7.72 USD
-0.58 (-6.99%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $7.70 -0.02 (-0.26%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Xeris Biopharma Holdings, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
XERS 7.72 -0.58(-6.99%)
Will XERS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for XERS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XERS
What Makes Xeris Biopharma (XERS) a Strong Momentum Stock: Buy Now?
Xeris Biopharma (XERS) Upgraded to Buy: Here's Why
XERS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run?
Xeris Biopharma (XERS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Xeris Biopharma (XERS) Reports Q2 Loss, Tops Revenue Estimates
Other News for XERS
Is XERS showing upside potential? Crossed Above 20 Day Moving Average shows up after surging 8.21%
Stochastic Buy Signal appears for XERS after 2.68% move
Xeris Pharmaceuticals (XERS) Receives a Buy from H.C. Wainwright
Bollinger Band Squeeze appears for XERS after 1.49% move
XERS forms Stochastic Reached Oversold on September 15